N/A
Loading page data
Please wait a moment
Loading page data
Please wait a moment
Second Floor, 150 Fleet Street,
London, EC4A 2DQ.
+44 203-837-5656
108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018
+1 646-878-6329
IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.
+91 906 779 3500
Diabetes testing systems are the systems used at home or health care settings for monitoring the blood glucose levels in diabetic patients. Testing blood glucose level is the best way to understand diabetes and how different foods, medications, and other activities affect diabetes. Therefore, there is a need to keep a track of the blood glucose level in the body.
There are various types of devices available in the market to check the blood glucose level. The global diabetes testing systems market is likely to expand during the forecast period with the increasing prevalence of diabetes and innovative product launches across the globe.
Pandemic coronavirus is believed to have a severe impact on the global diabetes testing systems market. Diabetes testing systems manufacturing industries are being shuttered around the world causing an unusual technology and business model transformation.
There has been a disruption in the production and supply of diabetes testing systems due to the global restrictions. Also, due to the initial lockdown, the industries are now facing a demand shock with an uncertain recovery timeline.
The increasing prevalence of diabetes across the globe is the major factor driving the growth of the global diabetes testing systems market. The increasing innovative product launches for the management of diabetes is likely to boost the global diabetes testing systems market growth.
The increasing demand for self-monitoring system and rising awareness of the systems available in the market are further likely to drive the growth of the global diabetes testing systems market. However, there are some factors which can restrain the growth of the global diabetes testing systems market such as high cost and poor reimbursement of the testing systems.
| Based on the product type |
|
| Based on the testing site |
|
| Based on the end-user |
|
Based on the product type, the self-monitoring diabetes testing systems segment is expected to hold a major share in the diabetes testing systems market due to the growing adoption of minimally invasive procedures. Based on the testing site, the fingertip testing site segment is expected to dominate the diabetes testing systems market due to the higher accuracy and reliability of fingertip testing.
Based on the end-user, the self/home care segment is expected to be the most dominating segment in the global diabetes testing systems market due to the increasing awareness about usage of glucose level monitoring system and rising product innovation enhancing patient comfort when used at home.
North America is expected to dominate the global diabetes testing systems market due to the increasing prevalence of diabetes and adoption of various awareness programs. Also, favourable reimbursements and rising FDA approvals is likely to drive the diabetes testing systems market in the region.
Europe is expected to be the next, due to the rising prevalence of diabetes in the region. Asia-Pacific is expected to have a significant growth in the global diabetes testing systems market over the forecast period due to the increasing awareness of diabetes testing systems usage, and rising healthcare expenditure. Also increasing population in countries like China and India is further likely to boost the diabetes testing systems market growth in the region.
Some of the market participants in the global diabetes testing systems market identified across the value chain include: Roche Holding AG, Abbott Laboratories, Sanofi S.A., ACON Laboratories, Nova Biomedical, Nipro Corporation, B. Braun Holding GmbH, DexCom, Medtronic plc, ARKRAY, and others.
